Delivery Order SPE2DB24D2205-SPE2DB25FEFKG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,237.54 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This non-competitive delivery order, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price purchase under the company's existing contract vehicle. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,882.23 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. The contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price procurement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,257.48 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of July 15, 2025. The contract is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed-price contract valued at $6,287.40. The delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a non-set-aside competitive award. The vaccine will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,257.48 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, non-set-aside contract for delivery to AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting the federal government's medical supply needs through AmerisourceBergen's established vendor...
- The Defense Logistics Agency awarded a $2,095.80 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The vaccine will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,095.80 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by September 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order operates under a firm fixed price structure and represents a discrete transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $16,766.40 to AmerisourceBergen Drug Corp for the supply of Rabavert rabies vaccine with diluents. The contract is firm fixed price with no set-aside designation and was competitively awarded on August 29, 2025, with an ultimate completion date of September 2, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed-price contract valued at $18,728.13. The order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued...
- The Defense Logistics Agency awarded a $20,958 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, will deliver this vaccine...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFKGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,258.65 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This contract, issued July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed price delivery order with no set-aside designation. The vaccine will be delivered to the contractor's facility in Conshohocken, Pennsylvania, supporting federal medical procurement requirements across the defense and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. That prime contract vehicle serves as a comprehensive global pharmaceutical support program enabling the company to supply a wide range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, has demonstrated consistent capability to meet federal procurement requirements through competitive awards across multiple therapeutic domains, including vaccines, specialty medications, and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/25/25 |